Chronic obstructive pulmonary disease (COPD) is one of the diseases with the greatest financial burdens worldwide and within the United States. Studies have shown that the average annual COPD-related expenditure is around $4,147. And while 51% of these costs are covered by Medicare according to the Centers for Disease Control and Prevention (CDC), that still leaves roughly $2,000 a year that COPD patients need to spend out-of-pocket. Combine this with the cost of aging and limited retirement funds and it’s not hard to see why COPD is such a major financial burden for so many people.
Supplemental oxygen therapy or long term oxygen therapy (LTOT), is an at home therapy process 1.5 million Americans utilize everyday in order to improve their quantity and quality of living with chronic lung diseases.